Details of the Drug Reposition

General Information of This Drug (ID: DMD9C1E)

• Drug Name: GBT-101 (DMD9C1E)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Epidermolysis bullosa	DISVOTZQ	EC3Z	Phase 2	[1]
Pressure ulcers	DIS2JDOY	EH90	Phase 2	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)